• Analysis and Studies
• Blood, antisera, vaccines, toxins and cultures

Blood, antisera, vaccines, toxins and cultures are the world's 12th most traded product, with a total trade of $192B. In the last years, the exports of Blood, antisera, vaccines, toxins and cultures grew by 21.6%, from  $158B to $192B.

Exports: Ireland ($32.9B), Germany ($29.7B), Switzerland ($28B), United States ($27.2B), and Belgium-Luxembourg ($16.2B).

Imports: In 2018 the top importers of Blood, antisera, vaccines, toxins and cultures were United States ($39B), Germany ($19.1B), Belgium-Luxembourg ($16.3B), Netherlands($11.5B), and Switzerland ($9.9B).

Ranking: Blood, antisera, vaccines, toxins and cultures ranks 110th in the Product Complexity Index.